The US House Foreign Affairs Subcommittee on East Asia and the Pacific held a hearing focused on China's central role in the fentanyl crisis devastating American communities. Lawmakers and experts emphasized that while Mexican cartels manufacture and distribute fentanyl, the supply chain’s origin traces back to precursor chemicals produced in China.

Subcommittee Chair Representative Young Kim accused Beijing of allowing factories that produce these chemical precursors to operate unchecked, asserting that the Chinese Communist Party values the ongoing harm caused to Americans. She questioned why Chinese authorities have not acted against individuals and companies implicated in fentanyl trafficking despite US sanctions and indictments.

Ranking member Representative Ami Bera called for a comprehensive response, highlighting prevention, education, and treatment alongside efforts to curb supply chains. He framed the opioid crisis as a nonpartisan public health emergency affecting tens of thousands of Americans every day.

Witnesses underlined China’s pivotal position in the fentanyl supply chain. Steve Yates from the Heritage Foundation, whose daughter died from fentanyl-laced pills, described China as the primary global source of precursor chemicals and pill pressing equipment for Mexican cartels. Yates urged Congress to intensify sanctions and reduce reliance on Chinese pharmaceutical imports, framing the epidemic as a national security crisis.

David Luckey, involved in shaping the 2026 National Drug Control Strategy, highlighted the need for enhanced bilateral and multilateral collaboration. He recommended tighter monitoring of China’s chemical exports and stronger measures against money laundering networks linked to drug trafficking.

In contrast, expert Zongyuan Zoe Liu offered a more nuanced view, stating there is no concrete evidence Beijing intentionally directs illicit fentanyl production. This perspective calls for a careful distinction between deliberate state policy and gaps in enforcement.

  • The hearing focused on China’s manufacturing of fentanyl precursor chemicals.
  • US lawmakers accused Beijing of tolerating production facilities linked to trafficking.
  • Experts urged stronger sanctions and tighter export regulations.
  • Calls were made for increased international cooperation and drug treatment initiatives.